Please cite this article in press as: Gamal-Eldeen AM, et al. Photodynamic therapeutic role of indocya-
nine green in tumor-associated inflammation in skin cancer. Photodiagnosis and Photodynamic Therapy (2014),
http://dx.doi.org/10.1016/j.pdpdt.2014.03.002
ARTICLE IN PRESS
+Model
PDPDT-544; No. of Pages 11
Photodiagnosis and Photodynamic Therapy (2014) xxx, xxx—xxx
Available online at www.sciencedirect.com
ScienceDirect
jou rn al hom epage: www.elsevier.com/locate/pdpdt
Photodynamic therapeutic role of
indocyanine green in tumor-associated
inflammation in skin cancer
Amira M. Gamal-Eldeen
a,b,*
, Lamiaa M. Fouad
c
,
Sherien M. El-Daly
d
, Enas A. El-Hussieny
e
,
Ezzeddin S. El Denshary
f
a
Cancer Biology Laboratory, Center of Excellence for Advanced Sciences, National Research Center, Cairo,
Egypt
b
Department of Biochemistry, National Research Center, Cairo, Egypt
c
Pharmaceutical Technical Examination, Egyptian Patent Office, Academy of Scientific Research and
Technology, Cairo, Egypt
d
Department of Medical Biochemistry, National Research Center, Cairo, Egypt
e
Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt
f
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
KEYWORDS
Photodynamic
therapy;
Indocyanine green;
5-Lipoxygenase;
Cyclooxygenase-2;
Tumor necrosis
factor-;
Proliferating cell
nuclear antigen
Summary
Background: Indocyanine green (ICG) is a promising water-soluble photosensitizer for photody-
namic therapy (PDT) of tumors. It was reported to have promising phototoxic effect on different
cell lines. This study aimed to evaluate the efficacy of ICG as an efficient PS agent for skin cancer
induced in mice.
Methods: Skin squamous cell carcinoma was induced in female CD-1 mice by 7,12-
dimethylbenzanthracene and 12-O-tetradecanoyl-phorbol-13-acetate followed by an ICG/PDT
treatment. The laser irradiation for PDT was adjusted to cover the whole body of the mice to
make sure that the treatment protocol will be delivered to multiple tumors.
Results: The treatment of skin cancer by ICG/PDT using intravenously injected ICG initiated
tumor cell death and significantly decreased cell proliferation as indicated by the reduction in
proliferating cell nuclear antigen positivity. A significant reduction in the inflammatory media-
tors; tumor necrosis factor-, nitric oxide and 5-lipoxygenase was reported, however the level
of cyclooxygenase-2 (COX-2) was significantly elevated after ICG/PDT treatment.
Conclusion: The proposed ICG/PDT treatment modality showed a significant anti-tumor and
anti-inflammatory activity against skin cancer accompanied with COX-2 elevation.
© 2014 Elsevier B.V. All rights reserved.
∗
Corresponding author at: NRC, Dokki, 12622 Cairo, Egypt. Tel.: +20 1006053903; fax: +20 233370931.
E-mail address: aeldeen7@yahoo.com (A.M. Gamal-Eldeen).
http://dx.doi.org/10.1016/j.pdpdt.2014.03.002
1572-1000/© 2014 Elsevier B.V. All rights reserved.